Target intelligence / Profile preview

ADAM metallopeptidase with thrombospondin type 1 motif 6 (ADAMTS6)

Target
ADAMTS6
Molecular classification
Enzyme, Metallopeptidase, Protease, Disintegrin, ADAMTS protein family
01

Overview

ADAM metallopeptidase with thrombospondin type 1 motif 6 (ADAMTS6) is a secreted, catalytically active metalloproteinase of the ADAMTS family, characterized by a metalloprotease domain, disintegrin-like domain, and multiple thrombospondin type 1 repeats. ADAMTS6 modulates the extracellular matrix by cleaving specific proteins, especially impacting microfibril assembly and cell-cell junction integrity. Increased ADAMTS6 activity disrupts epithelial cell-cell junctions (tight and adherens junctions), reduces deposition of microfibrils (such as fibrillin-1 and fibronectin), and depletes cell surface heparan sulfate by proteolytic cleavage, including of syndecan-4. These actions influence tissue architecture and homeostasis, and aberrant expression or activity is associated with connective tissue abnormalities, including predisposition to hernias and possible roles in other connective tissue diseases[1][2][3][6].

Other names
ADAM-TS6ADAMTS-6ADAM-TS 6A disintegrin and metalloproteinase with thrombospondin motifs 6A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 6EC 3.4.24.82EC 3.4.24.-[2][3]
02

Mechanism of action

Proteolytic cleavage of extracellular matrix components. Disruption of cell surface heparan sulfate and associated proteoglycans (such as syndecan-4).

03

Biological functions

Extracellular matrix organizationRegulation of cell-cell junctions (disrupts tight and adherens junctions)Modulation of focal adhesionsMicrofibril assembly (inhibits deposition of fibrillin-1 and fibronectin microfibrils)Proteolytic cleavage of extracellular proteins (e.g., syndecan-4)Binding to microfibrillar molecules
04

Disease associations

Connective tissue disorders (e.g., predisposition to hernias)Weill-Marchesani syndrome (implicated by gene family member mutation)Primary ovarian insufficiency (association)
05

Safety considerations

Limited data available; potential for off-target effects on connective tissue integrity due to role in extracellular matrix and cell adhesion

Beyond the preview

Go deeper on ADAM metallopeptidase with thrombospondin type 1 motif 6 (ADAMTS6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAM metallopeptidase with thrombospondin type 1 motif 6 (ADAMTS6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call